Floatz logo

Therapeutic Asset Ratings

13,145 results matching 1 filter

91,565 assets7,904 sponsors3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Tazemetostat
Ependymoma
National Cancer Institute (NCI)P2B (57)
Tazemetostat
Ewing Sarcoma
National Cancer Institute (NCI)P2B (57)
Tazemetostat
Glioma
National Cancer Institute (NCI)P2B (57)
Tazemetostat
Hepatoblastoma
National Cancer Institute (NCI)P2B (57)
Tazemetostat
Malignant Germ Cell Tumor
National Cancer Institute (NCI)P2B (57)
Tazemetostat
Medulloblastoma
National Cancer Institute (NCI)P2B (57)
Tazemetostat
Neuroblastoma
National Cancer Institute (NCI)P2B (57)
Tazemetostat
Osteosarcoma
National Cancer Institute (NCI)P2B (57)
Tazemetostat
Peripheral Primitive Neuroectodermal Tumor
National Cancer Institute (NCI)P2B (57)
Tazemetostat
Central Nervous System Neoplasm
National Cancer Institute (NCI)P2B (57)
Tazemetostat
Refractory Malignant Neoplasm
National Cancer Institute (NCI)P2B (57)
Tazemetostat
Wilms Tumor
National Cancer Institute (NCI)P2B (57)
tcb008
Acute Myeloid Leukemia
TC BiopharmP2B (57)
tcb008
Myelodysplastic Syndrome
TC BiopharmP2B (57)
Tegodor
Malignant Pancreatic Neoplasm
Ruijin HospitalP2B (57)
Tegodor
Pancreatic Neoplasm
Ruijin HospitalP2B (57)
Tenalisib
Breast Cancer
Rhizen Pharmaceuticals SAP2B (57)
Teonanacatl
Borderline Personality Disorder
University of ChicagoP2B (57)
Teonanacatl
Parkinson Disease
Yale UniversityP2B (57)
Tern-501
Metabolic Dysfunction-Associated Steatohepatitis
Terns, Inc.P2B (57)
Tern-601
Obesity Disorder
Terns, Inc.P2B (57)
Tesofensine
Acquired Hypothalamic Obesity
SanionaP2B (57)
Testosterone Cipionate
Hypogonadism
Brigham and Women's HospitalP2B (57)
Testosterone Cipionate
Vertebral Column Disorder
Brigham and Women's HospitalP2B (57)
Testosterone Cipionate
Prostate Adenocarcinoma
University of WashingtonP2B (57)
Showing 3501 to 3525 of 13,145 assets
PreviousPage 141 of 526Next